drug development Related News
Innovation and drug development with Tetra Bio-Pharma
Tetra Bio-Pharma executives speak out about building a cannabinoid pharmaceutical company.
For this article, we sat down for a virtual fireside chat with some key...
Deploying AI in drug discovery
AI healthcare upstart Aladdin continues to develop best-in-class AI technologies to advance and accelerate new breakthroughs in drug discovery.
In October 2020, UK-based healthcare technology...
Farxiga granted Breakthrough Therapy Designation by FDA
Farxiga has been given Breakthrough Therapy Designation by the Food and Drug Administration (FDA) for patients with chronic kidney disease.
Farxiga has recently shown encouraging...
First medicine to prolong survival in patients with chronic kidney disease
In a groundbreaking Phase III trial AstraZeneca’s Farxiga has shown reduction in the risk of kidney failure and cardiovascular or renal death in patients...
Investigation launched after Home Office psilocybin rescheduling response
MP Crispin Blunt has launched an economic investigation following the Home Office’s response to the recent call for the rescheduling of psilocybin.
The non-profit Conservative...
First at-home treatment for spinal muscular atrophy approved by FDA
The first at-home, orally administered treatment for spinal muscular atrophy has been approved by the US Food and Drug Administration (FDA).
The treatment – Evrysdi...
The UK Vaccine Taskforce: securing access to vaccines
Kate Bingham, Chair of the UK Vaccine Taskforce, discusses the three goals of the taskforce.
The UK Vaccine Taskforce has three key goals: to secure...
Cannabinoid therapies aim to address unmet medical needs
Oxford Cannabinoid Technologies (OCT) has appointed a new Chief Scientific Officer to help deliver cannabinoid therapies for unmet medical needs.
Dr Valentino Parravicini, PhD will...
Farxiga meets endpoints in trial for the treatment of chronic kidney disease
Farxiga has been shown to significantly reduce the worsening of renal function or risk of death in patients with chronic kidney disease with and...
Farxiga granted Fast Track Designation for heart failure treatment
The drug Farxiga has been granted Fast Track Designation in the US for evaluation in the treatment of heart failure.
AstraZeneca has been granted Fast...
Flaccid myelitis: researchers identify antibodies for rare children’s disease
Protective antibodies for the rare children’s disease – flaccid myelitis – have been identified by researchers, who hope the find could lead to future...
Potential new treatment for skin cancer with wearable patch development
A skin patch development could pave the way for new skin cancer treatments in the future that would not require chemotherapy or radiotherapy.
Scientists have...
Experimental cancer drug is potential treatment for rare Rett syndrome
Scientists have investigated the use of an experimental cancer drug for the treatment of the rare Rett syndrome, finding that it extended life in...
Could these senolytic drugs halt the spread of COVID-19?
Professor Michael Lisanti of Salford University highlights the potential application of senolytic drugs in combating COVID-19.
Professor Michael P Lisanti, Chair in Translational Medicine at...
UK companies to supply drugs for major UK COVID-19 drugs trial
Four drugs have been announced as the first to be involved with a major COVID-19 drugs trial that will be testing their efficacy for...
Could arketamine be a breakthrough therapy for depression?
Clinical trials are being carried out to test the efficacy of arketamine as therapy for depression, with the aim of offering an alternative to...
Better control of blood sugar for diabetics with two-in-one injection
An experimental two-in-one insulin injection has been created to help diabetics gain better control of their blood sugar.
The injection, developed by researchers at Stanford...
Drug combination shows promise for treating COVID-19
New findings have shown that a triple antiviral drug combination holds promise for the treatment of COVID-19.
Results from a randomised trial for treating COVID-19...
Drug candidate as potential therapy for cytokine release syndrome
Preclinical proof of concept of PPP003 – a synthetic cannabinoid drug – has been put forward as potential therapy in the battle against COVID-19...
New technique and AI could speed up antibody drug discovery
A new technique has been developed by scientists which, in combination with the use of artificial intelligence, could speed up potential new antibody-based drug...